rs10488598
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001006630.2(CHRM2):c.-125+33678T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.243 in 528,114 control chromosomes in the GnomAD database, including 18,758 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 4969 hom., cov: 32)
Exomes 𝑓: 0.25 ( 13789 hom. )
Consequence
CHRM2
NM_001006630.2 intron
NM_001006630.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.25
Genes affected
CHRM2 (HGNC:1951): (cholinergic receptor muscarinic 2) The muscarinic cholinergic receptors belong to a larger family of G protein-coupled receptors. The functional diversity of these receptors is defined by the binding of acetylcholine to these receptors and includes cellular responses such as adenylate cyclase inhibition, phosphoinositide degeneration, and potassium channel mediation. Muscarinic receptors influence many effects of acetylcholine in the central and peripheral nervous system. The muscarinic cholinergic receptor 2 is involved in mediation of bradycardia and a decrease in cardiac contractility. Multiple alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Jul 2008]
MIR490 (HGNC:32075): (microRNA 490) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.223 AC: 33934AN: 151836Hom.: 4970 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
33934
AN:
151836
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.252 AC: 94650AN: 376160Hom.: 13789 Cov.: 0 AF XY: 0.245 AC XY: 52541AN XY: 214574 show subpopulations
GnomAD4 exome
AF:
AC:
94650
AN:
376160
Hom.:
Cov.:
0
AF XY:
AC XY:
52541
AN XY:
214574
Gnomad4 AFR exome
AF:
AC:
572
AN:
10028
Gnomad4 AMR exome
AF:
AC:
6273
AN:
35150
Gnomad4 ASJ exome
AF:
AC:
3454
AN:
11644
Gnomad4 EAS exome
AF:
AC:
599
AN:
13012
Gnomad4 SAS exome
AF:
AC:
8475
AN:
65606
Gnomad4 FIN exome
AF:
AC:
9593
AN:
31320
Gnomad4 NFE exome
AF:
AC:
60515
AN:
190430
Gnomad4 Remaining exome
AF:
AC:
4420
AN:
16430
Heterozygous variant carriers
0
3772
7543
11315
15086
18858
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.223 AC: 33919AN: 151954Hom.: 4969 Cov.: 32 AF XY: 0.220 AC XY: 16372AN XY: 74278 show subpopulations
GnomAD4 genome
AF:
AC:
33919
AN:
151954
Hom.:
Cov.:
32
AF XY:
AC XY:
16372
AN XY:
74278
Gnomad4 AFR
AF:
AC:
0.0612923
AN:
0.0612923
Gnomad4 AMR
AF:
AC:
0.228125
AN:
0.228125
Gnomad4 ASJ
AF:
AC:
0.291979
AN:
0.291979
Gnomad4 EAS
AF:
AC:
0.0391051
AN:
0.0391051
Gnomad4 SAS
AF:
AC:
0.132048
AN:
0.132048
Gnomad4 FIN
AF:
AC:
0.306311
AN:
0.306311
Gnomad4 NFE
AF:
AC:
0.323925
AN:
0.323925
Gnomad4 OTH
AF:
AC:
0.255471
AN:
0.255471
Heterozygous variant carriers
0
1245
2491
3736
4982
6227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
348
696
1044
1392
1740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
337
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at